These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Dopaminergic modulation of the P50 auditory-evoked potential in a computer model of the CA3 region of the hippocampus: its relationship to sensory gating in schizophrenia. Moxon KA; Gerhardt GA; Adler LE Biol Cybern; 2003 Apr; 88(4):265-75. PubMed ID: 12690485 [TBL] [Abstract][Full Text] [Related]
5. Sensory gating in schizophrenia: P50 and N100 gating in antipsychotic-free subjects at risk, first-episode, and chronic patients. Brockhaus-Dumke A; Schultze-Lutter F; Mueller R; Tendolkar I; Bechdolf A; Pukrop R; Klosterkoetter J; Ruhrmann S Biol Psychiatry; 2008 Sep; 64(5):376-84. PubMed ID: 18395700 [TBL] [Abstract][Full Text] [Related]
7. Comparison of midlatency auditory sensory gating at short and long interstimulus intervals. Rentzsch J; de Castro AG; Neuhaus A; Jockers-Scherübl MC; Gallinat J Neuropsychobiology; 2008; 58(1):11-8. PubMed ID: 18781086 [TBL] [Abstract][Full Text] [Related]
8. [Sensory gating P50 in schizophrenic patients with and without homicide]. Wang HX; Zhen WF; Ma X; Wang YP; Tian JH; Dou QS; Zhao HX Zhonghua Yi Xue Za Zhi; 2009 Oct; 89(37):2616-20. PubMed ID: 20137678 [TBL] [Abstract][Full Text] [Related]
9. P50 gating at acute and post-acute phases of first-episode schizophrenia. Devrim-Uçok M; Keskin-Ergen HY; Uçok A Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):1952-6. PubMed ID: 18929611 [TBL] [Abstract][Full Text] [Related]
10. P50 sensory gating deficit is a common marker of vulnerability to bipolar disorder and schizophrenia. Sánchez-Morla EM; García-Jiménez MA; Barabash A; Martínez-Vizcaíno V; Mena J; Cabranes-Díaz JA; Baca-Baldomero E; Santos JL Acta Psychiatr Scand; 2008 Apr; 117(4):313-8. PubMed ID: 18241306 [TBL] [Abstract][Full Text] [Related]
11. Antipsychotic effects on auditory sensory gating in schizophrenia patients. Sánchez-Morla EM; Santos JL; Aparicio A; García-Jiménez MA; Villanueva C; Martínez-Vizcaíno V; Arango C Eur Neuropsychopharmacol; 2009 Dec; 19(12):905-9. PubMed ID: 19833483 [TBL] [Abstract][Full Text] [Related]
12. Contribution of different EEG frequencies to auditory evoked potential abnormalities in schizophrenia. Jansen BH; Hegde A; Boutros NN Clin Neurophysiol; 2004 Mar; 115(3):523-33. PubMed ID: 15036047 [TBL] [Abstract][Full Text] [Related]
13. Range of sensory gating values and test-retest reliability in normal subjects. Fuerst DR; Gallinat J; Boutros NN Psychophysiology; 2007 Jul; 44(4):620-6. PubMed ID: 17437554 [TBL] [Abstract][Full Text] [Related]
14. P50 suppression, prepulse inhibition, and startle reactivity in the same patient cohort suffering from posttraumatic stress disorder. Holstein DH; Vollenweider FX; Jäncke L; Schopper C; Csomor PA J Affect Disord; 2010 Oct; 126(1-2):188-97. PubMed ID: 20347156 [TBL] [Abstract][Full Text] [Related]
16. Auditory sensory gating deficit and cortical thickness in schizophrenia. Thoma RJ; Hanlon FM; Sanchez N; Weisend MP; Huang M; Jones A; Miller GA; Canive JM Neurol Clin Neurophysiol; 2004 Nov; 2004():62. PubMed ID: 16012689 [TBL] [Abstract][Full Text] [Related]
17. Development and gender in the P50 paradigm. Brinkman MJ; Stauder JE Clin Neurophysiol; 2007 Jul; 118(7):1517-24. PubMed ID: 17509936 [TBL] [Abstract][Full Text] [Related]
18. An initial report of a new biological marker for bipolar disorder: P85 evoked brain potential. Patterson JV; Sandman CA; Ring A; Jin Y; Bunney WE Bipolar Disord; 2009 Sep; 11(6):596-609. PubMed ID: 19689502 [TBL] [Abstract][Full Text] [Related]
19. [The follow-up study on P50 auditory sensory gating in naïve schizophrenia]. Wang HX; Zhang MD; Wang ZC; Chen XS; Lou FY; Liang JH; Chen C Zhonghua Yi Xue Za Zhi; 2010 Mar; 90(9):601-5. PubMed ID: 20450782 [TBL] [Abstract][Full Text] [Related]
20. Alterations of auditory p50 suppression in human fear conditioning and extinction. Kurayama T; Nakazawa K; Matsuzawa D; Yoshida S; Nanbu M; Suto C; Shimizu E Biol Psychiatry; 2009 Mar; 65(6):495-502. PubMed ID: 18976983 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]